Zenas & InnoCare Announce Promising Autoimmune Drug Deal
Zenas Biopharma has secured a global license from InnoCare Pharma to develop and commercialize orelabrutinib for multiple sclerosis and...
eClinical Tech News
New Partnership Accelerates Drug Development for Innovators
Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions have launched an integrated CMC partnership to deliver end-to-end...
New Hope for GLP-1 Nausea: NG101 Proof-of-Concept Data
Neurogastrx will present proof-of-concept data for NG101, an oral, peripherally restricted dopamine D2 receptor antagonist (metopimazine mesylate), in semaglutide-induced...
MannKind’s scPharma Buy Accelerates Cardiometabolic Growth
MannKind has closed its acquisition of scPharmaceuticals, bringing Furoscix, a subcutaneous furosemide injection for fluid overload in chronic heart...
New Atea Data Sparks Hope for Best-in-Class HCV Treatment
Atea Pharmaceuticals will present new data at AASLD’s Liver Meeting 2025 in Washington, DC, backing its fixed-dose combination of...
Relmada Adds Expert Oncologist to Promising Advisory Board
Relmada Therapeutics has appointed Max Kates, MD, a leading urologic oncologist from Johns Hopkins and chair of the large,...
Lexeo Announces Positive LX2006 Data for FA Cardiomyopathy
Lexeo Therapeutics reported that the FDA is open to a pooled-data strategy supporting an accelerated approval filing for LX2006,...
New Leqembi Subcutaneous Injection for Alzheimer’s Now in US
Eisai and Biogen have made Leqembi iqlik, a weekly 360 mg subcutaneous autoinjector, available in the U.S. as a...
High Court Approves MSD’s Successful Acquisition of Verona
MSD, the tradename of Merck & Co., will acquire Verona Pharma for $107 per American Depositary Share in a...
Profusa Adds Leading French CLI Surgeon to Customer Base
Profusa has expanded its European footprint through a collaboration with Yann Gouëffic, professor of vascular surgery at Groupe Hospitalier...